Marijuana Strategic Ventures, Inc. (OTC: MSVI) Announces Name Change to Mushrooms, Inc., New Management and Business Model

ESTERO, Fla, July 05, 2022 (GLOBE NEWSWIRE) -- Marijuana Strategic Ventures, Inc. (the “Company”) (OTC:MSVI) announces today that effective June 27, 2022, the Company has officially changed its name to Mushrooms, Inc., through the filing of amended and restated articles of incorporation with the Nevada Secretary of State. In addition to changing the Company’s corporate name to Mushrooms, Inc., the Company announces the appointment of a new Chief Executive Officer, Kimberly Carlson, focused on implementing a new business model based on functional mushrooms.

With the appointment of Kimberly Carlson as CEO, the Company’s former CEO, James Hancock, has been appointed the Chief Operating Officer of the Company. James Hancock resigned from the Company’s board of directors, leaving Donald Steinberg as the Company’s sole director.

Donald Steinberg, the Company’s director, commented, “The name change to Mushrooms, Inc. is fundamental to the Company’s shift from a focus on the cannabis industry to the functional mushroom industry. I am thrilled to announce that our new CEO, Kimberly Carlson, will lead the transition to the emerging mushroom industry. Over the years I have watched her build companies through collective collaboration with her peers and competition. Her ability to bring people together from a variety of areas is welcome as we move into the Mushroom world. This is a vastly growing industry that offers so much to health and the environment as she brings forth new products and ideas to the forefront. She combines functional creativity with a high level of administrative talents that are essential to success in a newly emerging market.”

Kimberly Carlson, CEO says “We see components of mushrooms successfully replacing leather, fiberglass insulation, packaging materials and so much more. This is a blossoming world that is just awakening into the minds of the consumer. The health benefits are continuing to unfold and the well-established contributions to wellness are being embraced in the marketplace. This is an exciting time to dive into the discovery and provide products that will not only benefit our bodies and minds but show that we can cost effectively switch to alternative methods of production that support the needed repair to our environment. We have divided our current business efforts into 3 major categories: Research & Development, Innovation, and Health. I believe this tri-focus will enable Mushrooms, Inc. to best develop, implement and share the benefits for mind, body and environment.”

New Website

We are excited to announce that we have launched a new website as part of the overall refocus of the Company. We encourage our customers and shareholders to visit the site regularly for updates and helpful information on our Company and products. This is a beta version of the website that will be updated further in the coming weeks.

Amended and Restated Articles of Incorporation, Bylaws, Symbol Change

In addition to the change of the Company’s name to Mushrooms, Inc., the amended and restated articles of incorporation were amended to increase the authorized number of shares of Series A Preferred Stock from 1,000,000 to 1,500,000, and to add the following provisions concerning: Management Matters, Stockholder Action, Bylaw provision, Board of Directors provision, Transactions with Stockholders provision, Limitation of Liability provision, Indemnification provision, Indemnification Provided in Bylaws provision, Place of Meeting, Corporate Books provision, Amended to Articles of Incorporation provision, and Exclusive Forum provision.

Subject to final approval by FINRA, Mushroom, Inc.’s Common Stock will continue to trade on the OTC Pink following the name change, The Company anticipates that the new ticker symbol for its Common Stock will be “MYCO” (or such other symbol as may be proposed by the Company and approved by FINRA). The effectiveness of the corporate name change and change in stock trading symbol is subject to approval by FINRA. Upon receipt of FINRA’s approval of the name and ticker symbol changes, the Company will update its OTC disclosure to provide the effective date of such name change and additional information regarding the Company’s new ticker symbol.

Also, on June 27, 2022, the Company’s board of directors and holders of a majority of the issued and outstanding capital stock of the Company approved, and the Company adopted, its Second Amended and Restated Bylaws, which amend and restate the Company’s First Amended and Restated Bylaws to, amongst other things: incorporate the name change of the Company to Mushrooms, Inc.

About Kimberly Carlson

Kimberly Carlson has repeatedly created meaningful and lasting connections between business, community and the environment. Working since the age of 16 and awarded at the age of 21 for her unique approach to her first start-up business, she has a passion for forging new path to success for business and community. She is able to find the mutually beneficial meeting point between the business and the consumer while always considering the environmental impact of actions taken. Her experiential marketing skills include creating proprietary live art performance events which have proven success in building the business and the brand. A belief that collaborations are essential has fueled her team building skills and employing creative minds has garnered much success for the businesses she has been integral in developing. She is forging new relationships in this industry and looks forward to working with the pioneers to garner mutual momentum for products benefiting the mind, body and the future of our planet. A

About Mushrooms Inc. (MSVI)
Mushrooms, Inc. is a publicly traded company on the OTC Markets with the stock symbol MSVI. We anticipate that the new ticker symbol for its Common Stock will be MYCO. We chose the trading symbol MYCO which is a prefix that denotes a relationship to fungus. From the Greek “mykes”, meaning fungus.

The vision for Mushrooms, Inc. is to support the growth of the mushroom industry through collaboration, innovation and development. Creating and supporting environmentally beneficial product innovation is at the heart of Mushrooms, Inc. Our current focus is on the industrial application of Mycelium for the creation of carbon neutral products for the building and health care industries as well as creating supplements based on the proven health benefits of mushrooms. Research and Development is the path to achieving great innovation and the pioneers are the ones we look to for their fortitude and enduring dedication to the world of mycology. The working relationships we are fostering will result in scientifically proven products that advance health of body, mind and environment.

For more information, email

Safe Harbor Statement

This release contains forward-looking statements that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although we believe that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, we can give no assurance or guarantee that such expectations and assumptions will prove to have been correct. Forward-looking statements are generally identifiable by the use of words like "may," "will," "should," "could," "expect," "anticipate," "estimate," "believe," "intend," or "project" or the negative of these words or other variations on these words or comparable terminology. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous factors and uncertainties, including but not limited to: adverse economic conditions, competition, adverse federal, state and local government regulation, international governmental regulation, inadequate capital, inability to carry out research, development and commercialization plans, loss or retirement of key executives and other specific risks. To the extent that statements in this press release are not strictly historical, including statements as to revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future financial conditions, events conditioned on stockholder or other approval, or otherwise as to future events, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made.

Corporate Contact:

Mushrooms, Inc.

CEO: Kimberly Carlson
Tel: (877) 379-5400